Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 16 | 2025 | 70 | 3.890 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2025 | 104 | 3.810 |
Why?
|
| Crohn Disease | 7 | 2022 | 71 | 2.680 |
Why?
|
| Proctocolectomy, Restorative | 12 | 2017 | 21 | 2.520 |
Why?
|
| alpha-Defensins | 3 | 2025 | 22 | 2.090 |
Why?
|
| Colon | 4 | 2025 | 120 | 1.610 |
Why?
|
| Antibodies, Monoclonal | 2 | 2025 | 306 | 1.600 |
Why?
|
| Colitis | 2 | 2025 | 71 | 1.530 |
Why?
|
| Proteomics | 5 | 2021 | 378 | 0.980 |
Why?
|
| Triglycerides | 2 | 2024 | 147 | 0.970 |
Why?
|
| Intestinal Mucosa | 5 | 2017 | 134 | 0.940 |
Why?
|
| Colonic Pouches | 3 | 2011 | 10 | 0.920 |
Why?
|
| Epitopes | 1 | 2025 | 157 | 0.890 |
Why?
|
| Superoxides | 1 | 2024 | 57 | 0.850 |
Why?
|
| Receptors, LDL | 1 | 2024 | 42 | 0.840 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 13 | 0.800 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 512 | 0.750 |
Why?
|
| Insulin Resistance | 1 | 2024 | 201 | 0.730 |
Why?
|
| Enterotoxins | 1 | 2021 | 33 | 0.680 |
Why?
|
| Mice, Knockout | 1 | 2024 | 1035 | 0.670 |
Why?
|
| Organoids | 1 | 2021 | 37 | 0.670 |
Why?
|
| Oxidative Stress | 2 | 2024 | 1003 | 0.620 |
Why?
|
| Obesity | 1 | 2024 | 1151 | 0.470 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2015 | 102 | 0.460 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 223 | 0.450 |
Why?
|
| Ileostomy | 3 | 2006 | 7 | 0.440 |
Why?
|
| alpha-Globins | 1 | 2014 | 4 | 0.440 |
Why?
|
| Humans | 23 | 2025 | 43102 | 0.390 |
Why?
|
| Precancerous Conditions | 2 | 2011 | 83 | 0.380 |
Why?
|
| Adenocarcinoma | 2 | 2011 | 291 | 0.340 |
Why?
|
| Mucous Membrane | 1 | 2010 | 34 | 0.330 |
Why?
|
| Anus Neoplasms | 1 | 2011 | 44 | 0.320 |
Why?
|
| Mice | 3 | 2025 | 6644 | 0.300 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2009 | 20 | 0.300 |
Why?
|
| Proteome | 1 | 2010 | 152 | 0.300 |
Why?
|
| Gastrointestinal Hormones | 1 | 2007 | 2 | 0.270 |
Why?
|
| Blood Proteins | 2 | 2015 | 77 | 0.260 |
Why?
|
| Postoperative Complications | 1 | 2009 | 263 | 0.260 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2006 | 13 | 0.260 |
Why?
|
| Prostatic Hyperplasia | 1 | 2006 | 32 | 0.250 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 532 | 0.250 |
Why?
|
| Male | 14 | 2024 | 23409 | 0.250 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 27 | 0.240 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 54 | 0.240 |
Why?
|
| Liver Diseases | 1 | 2006 | 34 | 0.240 |
Why?
|
| Electrolytes | 1 | 2006 | 30 | 0.240 |
Why?
|
| Antioxidants | 2 | 2023 | 443 | 0.240 |
Why?
|
| Epitope Mapping | 1 | 2025 | 32 | 0.230 |
Why?
|
| Surface Plasmon Resonance | 1 | 2025 | 42 | 0.230 |
Why?
|
| Lipoproteins, VLDL | 1 | 2024 | 4 | 0.220 |
Why?
|
| Mice, Obese | 1 | 2024 | 42 | 0.210 |
Why?
|
| Aged | 6 | 2021 | 8214 | 0.210 |
Why?
|
| Lipids | 1 | 2006 | 256 | 0.210 |
Why?
|
| Haptoglobins | 1 | 2023 | 10 | 0.200 |
Why?
|
| Deferoxamine | 1 | 2023 | 17 | 0.200 |
Why?
|
| Animals | 3 | 2025 | 16992 | 0.200 |
Why?
|
| Peptides | 1 | 2006 | 372 | 0.200 |
Why?
|
| Leptin | 1 | 2024 | 118 | 0.200 |
Why?
|
| Adenomatous Polyposis Coli | 3 | 2007 | 28 | 0.190 |
Why?
|
| Erythrocytes | 1 | 2023 | 126 | 0.190 |
Why?
|
| Retrospective Studies | 2 | 2021 | 2544 | 0.190 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 183 | 0.180 |
Why?
|
| Adolescent | 7 | 2014 | 6081 | 0.180 |
Why?
|
| Myocardium | 1 | 2024 | 263 | 0.180 |
Why?
|
| Middle Aged | 10 | 2014 | 12222 | 0.180 |
Why?
|
| Mucin-6 | 1 | 2021 | 7 | 0.170 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 101 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2008 | 1092 | 0.170 |
Why?
|
| Female | 11 | 2021 | 24698 | 0.170 |
Why?
|
| Cell Lineage | 1 | 2021 | 104 | 0.160 |
Why?
|
| Pouchitis | 2 | 2011 | 4 | 0.160 |
Why?
|
| Immunoglobulins | 1 | 2000 | 39 | 0.160 |
Why?
|
| Lipoproteins, HDL | 1 | 2000 | 48 | 0.150 |
Why?
|
| Gastrins | 1 | 1999 | 9 | 0.150 |
Why?
|
| Gastric Acid | 1 | 1999 | 11 | 0.150 |
Why?
|
| Macrophages | 1 | 2023 | 529 | 0.150 |
Why?
|
| Adult | 9 | 2015 | 13872 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2022 | 549 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 1869 | 0.140 |
Why?
|
| Cholesterol | 1 | 2000 | 232 | 0.140 |
Why?
|
| Logistic Models | 1 | 2021 | 1009 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2021 | 434 | 0.130 |
Why?
|
| Muramidase | 1 | 2017 | 30 | 0.130 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 1067 | 0.130 |
Why?
|
| Biopsy | 1 | 2017 | 177 | 0.130 |
Why?
|
| Cells, Cultured | 1 | 2021 | 1621 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 238 | 0.130 |
Why?
|
| Postoperative Period | 3 | 2006 | 33 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2015 | 883 | 0.120 |
Why?
|
| Apolipoprotein B-100 | 1 | 2015 | 7 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 934 | 0.110 |
Why?
|
| Clusterin | 1 | 2015 | 9 | 0.110 |
Why?
|
| Ceruloplasmin | 1 | 2015 | 15 | 0.110 |
Why?
|
| Peptide Mapping | 2 | 2015 | 20 | 0.110 |
Why?
|
| Comet Assay | 1 | 2014 | 77 | 0.110 |
Why?
|
| Anemia | 1 | 1994 | 55 | 0.110 |
Why?
|
| Prognosis | 2 | 2014 | 861 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 704 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 23 | 0.100 |
Why?
|
| Hemoglobins | 2 | 2009 | 113 | 0.100 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 92 | 0.100 |
Why?
|
| Young Adult | 2 | 2014 | 5080 | 0.100 |
Why?
|
| DNA Damage | 1 | 2014 | 356 | 0.090 |
Why?
|
| Risk Factors | 2 | 2011 | 3994 | 0.090 |
Why?
|
| Cell Survival | 1 | 2014 | 945 | 0.080 |
Why?
|
| Discriminant Analysis | 1 | 2010 | 25 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 165 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2011 | 246 | 0.080 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2009 | 4 | 0.080 |
Why?
|
| Folic Acid Deficiency | 1 | 2009 | 6 | 0.080 |
Why?
|
| Transferrin | 1 | 2009 | 38 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2006 | 1600 | 0.070 |
Why?
|
| Incidence | 1 | 2011 | 1078 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2853 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 154 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2006 | 10 | 0.060 |
Why?
|
| Hematology | 1 | 2006 | 2 | 0.060 |
Why?
|
| Prevalence | 1 | 2009 | 1612 | 0.050 |
Why?
|
| Quality of Life | 1 | 2009 | 616 | 0.050 |
Why?
|
| Child | 2 | 2015 | 3443 | 0.050 |
Why?
|
| Liver | 1 | 2006 | 511 | 0.050 |
Why?
|
| Greece | 1 | 2015 | 21 | 0.030 |
Why?
|
| Schilling Test | 1 | 1994 | 1 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 1994 | 4 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 114 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 1994 | 23 | 0.030 |
Why?
|
| Folic Acid | 1 | 1994 | 49 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1994 | 13 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1994 | 20 | 0.030 |
Why?
|
| Preoperative Care | 1 | 1994 | 32 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 1994 | 25 | 0.030 |
Why?
|
| Iron | 1 | 1994 | 251 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 719 | 0.020 |
Why?
|
| Chemokine CCL4 | 1 | 2008 | 19 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Chemokine CX3CL1 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 95 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 159 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2008 | 70 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 611 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1285 | 0.010 |
Why?
|